If you have been hearing about semaglutide, tirzepatide, Ozempic, or Wegovy and wondering whether medical weight loss could actually work for you, this guide is for you. At TOCC Aesthetics in Boynton Beach, Tiffany Jarrett offers medical weight loss through GLP-1 receptor agonist therapy for patients who have struggled to achieve lasting results through diet and exercise alone.
This is not a trend. The science behind GLP-1 therapy is among the most robust in modern medicine, and the results it produces in appropriate candidates are genuinely significant. But understanding what this treatment actually does to your body, who qualifies, and what to expect is essential before you decide whether it is right for you.
What Is GLP-1 Therapy and Why Is It Different from Other Weight Loss Approaches?
GLP-1 stands for glucagon-like peptide-1, a naturally occurring hormone produced in your gut in response to eating. In people with metabolic dysfunction or obesity, this hormone signaling is often blunted or dysregulated, which is one of the biological reasons willpower alone is an incomplete tool for long-term weight management.
GLP-1 receptor agonists are medications that mimic this hormone and amplify its effects. The most widely used GLP-1 medications in medical weight loss programs today are:
- Semaglutide (sold under brand names Ozempic for diabetes management and Wegovy for weight loss)
- Tirzepatide (sold under brand names Mounjaro for diabetes management and Zepbound for weight loss), which targets both GLP-1 and GIP receptors for an amplified effect
These medications work through mechanisms that are fundamentally different from stimulants, appetite suppressants, or meal replacement programs. They address the underlying biology of hunger, satiety, and metabolism rather than simply trying to override it.
What GLP-1 Therapy Actually Does to Your Body: The Science Explained Simply
1. It Slows Gastric Emptying
One of the primary actions of GLP-1 receptor agonists is significantly slowing the rate at which food leaves your stomach. This means food stays in your stomach longer after each meal, which prolongs the sensation of fullness and naturally reduces how often you want to eat and how much you want to consume. You are not fighting hunger. Your body is genuinely telling you it is satisfied.
2. It Reduces Appetite Signaling in the Brain
GLP-1 receptors exist not just in the gut but in the hypothalamus, the brain region that regulates hunger, appetite, and reward-seeking behavior around food. GLP-1 therapy directly reduces the neurological drive to eat by modulating these signals. Patients consistently report that food noise, the constant background mental preoccupation with food that characterizes obesity, quiets significantly within the first few weeks of treatment.
3. It Improves Insulin Sensitivity and Blood Sugar Regulation
GLP-1 agonists stimulate insulin secretion from the pancreas in a glucose-dependent manner, meaning they only drive insulin release when blood sugar is elevated. This reduces the sharp post-meal blood sugar spikes that trigger energy crashes, cravings, and fat storage. Over time, patients on GLP-1 therapy often see measurable improvements in fasting glucose, insulin sensitivity, and metabolic markers.
4. It Reduces Inflammation
Emerging research suggests GLP-1 agonists have meaningful anti-inflammatory effects that extend beyond their metabolic actions. Chronic low-grade inflammation is a driver of weight gain, metabolic dysfunction, and accelerated aging, and GLP-1 therapy appears to attenuate these inflammatory pathways in multiple organ systems.
GLP-1 therapy does not make losing weight easy by tricking the body. It corrects a biological signaling deficit that was making weight loss abnormally difficult in the first place.
What Results Can You Realistically Expect from Medical Weight Loss in Boynton Beach?
Clinical trial data for semaglutide (Wegovy) shows an average of 15% total body weight loss over 68 weeks in adults with obesity. Tirzepatide (Zepbound) trials produced average weight loss of 20 to 22% of total body weight. These are averages. Individual results vary based on starting weight, dose, adherence, lifestyle factors, and the specific medication used.
In practical terms, for a patient starting at 200 pounds:
- Semaglutide at full dose: average expected loss of 28 to 34 pounds over 12 to 18 months
- Tirzepatide at full dose: average expected loss of 38 to 48 pounds over 12 to 18 months
These are not the results of crash diets. They represent sustained metabolic change while patients eat in a way that feels manageable, not deprived.
Who Qualifies for Medical Weight Loss at TOCC Aesthetics?
GLP-1 therapy is a medical treatment and appropriate candidacy is assessed at your consultation with Tiffany Jarrett. General qualifying criteria include:
- Adults with a BMI of 30 or higher (clinical obesity), or BMI of 27 or higher with at least one weight-related health condition such as type 2 diabetes, high blood pressure, or high cholesterol
- Adults who have not achieved adequate weight loss through diet and lifestyle changes alone
- Patients without a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
- Patients who are not pregnant or planning pregnancy
- Patients without a history of pancreatitis (assessed case by case)
At your consultation, Tiffany reviews your health history, discusses your weight loss goals and previous experiences, and determines whether GLP-1 therapy is appropriate for you and which medication and dosing approach makes the most sense.
What Does the Medical Weight Loss Program at TOCC Aesthetics Look Like?
Starting Dose and Titration
GLP-1 medications are started at a low dose and titrated upward gradually over several weeks or months. This gradual escalation allows your body to adjust to the medication and minimizes the most common side effects, which are gastrointestinal in nature. The vast majority of patients who experience nausea, the most common reported side effect, find it manageable and temporary, particularly when titration is done patiently.
Ongoing Monitoring
Tiffany monitors your progress, reviews how you are tolerating the medication, and adjusts dosing based on your individual response. Medical weight loss is not a prescription in a box. It is an ongoing clinical program with the support of a provider who knows your case.
Complementary Wellness Support
At TOCC Aesthetics, medical weight loss patients can also explore complementary wellness services including peptide therapy and IV hydration, which can support energy levels, nutrient status, and recovery during active weight loss. Significant weight loss can also produce changes in facial volume and skin laxity over time, and Tiffany can help you plan for maintaining your aesthetic results alongside your weight loss goals.
What About Skin Laxity After Weight Loss?
This is an important question that many patients do not think to ask until they are deep into their weight loss journey. Significant weight loss, particularly when it occurs over 12 to 18 months, can result in a reduction in facial fullness, mild skin laxity in the lower face and neck, and changes in facial contour.
At TOCC Aesthetics, Tiffany is positioned to help patients manage these changes. Options including RF microneedling for skin tightening, PRF therapy for collagen stimulation, and other aesthetic treatments can complement your weight loss results and help your face reflect how you feel. Many medical weight loss patients at TOCC Aesthetics integrate aesthetic treatments into their overall wellness plan.
Is Medical Weight Loss in Boynton Beach Right for You?
If you have struggled with your weight despite genuine effort, if you have tried diets, programs, and approaches that worked temporarily but never produced lasting change, GLP-1 therapy may represent the most meaningful intervention available to you. The biology of obesity is real, and it is not a character flaw. It is a medical condition with medical solutions.
At TOCC Aesthetics in Boynton Beach, the medical weight loss consultation with Tiffany Jarrett is designed to give you honest, science-based guidance about whether this treatment is appropriate for your situation, what you can realistically expect, and how to approach it in a way that is sustainable.
Ready to explore medical weight loss in Boynton Beach, FL? Book your consultation with Tiffany Jarrett at TOCC Aesthetics. Call (561) 369-1101 or visit tocc.automatikpro.com/book-an-appointment/
Frequently Asked Questions: Medical Weight Loss and GLP-1 Therapy
Is semaglutide the same as Ozempic?
Semaglutide is the active ingredient in both Ozempic and Wegovy. Ozempic is FDA-approved specifically for type 2 diabetes management and is prescribed at lower doses. Wegovy is FDA-approved specifically for chronic weight management and is prescribed at higher doses designed to produce meaningful weight loss in patients with obesity. At TOCC Aesthetics, the appropriate formulation and dose are determined at your consultation based on your health history and goals.
How long do I need to stay on GLP-1 medication?
GLP-1 therapy is generally considered a long-term treatment rather than a short-term course. Clinical data shows that patients who discontinue the medication without having made sustainable lifestyle changes typically regain a significant portion of lost weight within 12 months. The most successful patients use the medication as a tool to reset their relationship with food, build sustainable habits during treatment, and work with their provider on a long-term plan. Tiffany discusses this frankly at consultation.
What are the most common side effects of GLP-1 therapy?
The most commonly reported side effects are gastrointestinal: nausea, constipation, and reduced appetite. These are most pronounced during dose escalation and typically diminish as the body adjusts. Slowing the titration schedule reduces these effects significantly for most patients. Serious adverse events are rare but are reviewed thoroughly at your consultation.
Does insurance cover medical weight loss treatment at TOCC Aesthetics?
Coverage varies significantly by insurance plan and medication. Wegovy and Zepbound have variable coverage across commercial plans, with some plans covering them and others explicitly excluding them. Medicare currently covers Wegovy for patients with established cardiovascular disease under specific criteria. Tiffany’s team can discuss your options and the self-pay cost of the program at your consultation.
Can I do Botox or other aesthetic treatments while on GLP-1 therapy?
Yes. GLP-1 therapy has no contraindication with Botox, microneedling, facials, or other aesthetic treatments at TOCC Aesthetics. Many patients combine their weight loss program with aesthetic treatments and find that having both conversations with the same provider, Tiffany Jarrett, makes coordinating their overall plan much simpler.
TOCC Aesthetics offers medical weight loss with GLP-1 therapy in Boynton Beach, FL at 2800 S Seacrest Blvd Suite 180. Tiffany Jarrett serves patients throughout Palm Beach County including Delray Beach, Boca Raton, Lake Worth, and Boynton Beach. Call (561) 369-1101 to schedule your consultation.